Font

Aa Aa Aa

Background color

A A

Site version

Color Black and white
Drugs

Omeprazolе-Darnitsa

Drugs for the treatment of peptic ulcers and gastroesophageal reflux disease. Proton pump inhibitors

Omeprazole is an anti-ulcer anti-secretory medicine. It easily enters into the parietal cells of the gastric mucosa, concentrates inside them and activates at an acidic pH.

Benign gastric and duodenal ulcers, including those specifically associated with the use of nonsteroidal anti-inflammatory drugs; Helicobacter pylori eradication (as part of combination therapy with antibacterial agents); gastroesophageal reflux disease; prevention of aspiration of the acidic stomach contents; Zollinger-Ellison syndrome; relieving the symptoms of acid-dependent dyspepsia.

Take orally before or during meals, without chewing or damaging the capsule, with a small amount of liquid. The dosage regimen depends on the type and severity of the disease and is selected by the physician individually for each patient.

Adults and children over 12 years.

Gastric and duodenal ulcers: the daily dose is 1 capsule. The usual treatment course for duodenal ulcers is 4 weeks, for stomach ulcers — 8 weeks. If necessary, the daily dose can be increased to 2 capsules.

Treatment and prevention of duodenal and gastric ulcers, as well as gastroduodenal erosion and dyspeptic symptoms associated with the use of nonsteroidal anti-inflammatory drugs: the recommended daily dose is 20 mg. The treatment course is 4 to 8 weeks.

Children.

The medicine is used in children over 5 years of age as prescribed by a physician for reflux oesophagitis and symptomatic treatment of heartburn and acid reflux in gastroesophageal reflux disease, and for the treatment of duodenal ulcers due to H. pylori, under the physician's control.

Specialized edition for medical institutions and doctors.